Moreover, it was reported that the interplay between Syk and Lyn has a role in mediating nilotinib resistance in K562 cell line and in CD34+ cells isolated from CML patient blood samples [38]. This evidence concerns the gene SYK and chronic myelogenous leukemia, BCR-ABL1 positive.